Consolidated Statement Of Income

STELLA PHARMA CORPORATION - Filing #7320249

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Consolidated statement of income
Statement of income
Net sales
269,491,000 JPY
229,067,000 JPY
Operating expenses
Selling, general and administrative expenses
977,598,000 JPY
1,013,719,000 JPY
Depreciation
13,613,000 JPY
14,587,000 JPY
Operating expenses
Operating expenses - general
Operating expenses
Gross profit (loss)
217,298,000 JPY
206,944,000 JPY
Operating profit (loss)
-760,300,000 JPY
-806,775,000 JPY
Ordinary profit (loss)
-760,208,000 JPY
-775,974,000 JPY
Operating expenses
Research and development expenses
393,555,000 JPY
374,345,000 JPY
General and administrative expenses
Net sales
Selling, general and administrative expenses
Non-operating income
Interest income
11,000 JPY
1,000 JPY
Interest on securities
1,428,000 JPY
1,425,000 JPY
Other
584,000 JPY
11,000 JPY
Non-operating income
4,624,000 JPY
40,620,000 JPY
Extraordinary losses
768,000 JPY
JPY
Non-operating expenses
Interest expenses
2,084,000 JPY
2,580,000 JPY
Other
JPY
81,000 JPY
Non-operating expenses
4,533,000 JPY
9,818,000 JPY
Share issuance costs
2,448,000 JPY
1,193,000 JPY
Profit (loss) before income taxes
-760,976,000 JPY
-775,974,000 JPY
Gross profit
Income taxes - current
2,772,000 JPY
2,850,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
768,000 JPY
JPY
Income taxes
2,772,000 JPY
2,850,000 JPY
Profit (loss)
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-778,824,000 JPY
-778,824,000 JPY
-778,824,000 JPY
-778,824,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.